What were the key takeaways from SRx Health’s earnings call?

What is the revenue and EPS growth rate for SRx Health year over year?

What is the market's earnings forecast for SRx Health next quarter?

What does SRx Health do and what are its main business segments?

What guidance did SRx Health's management provide for the next earnings period?

What were the key takeaways from SRx Health's earnings call?

What factors drove the changes in SRx Health's revenue and profit?

What is SRx Health's latest dividend and current dividend yield?

- **Gross Margin Transformation**: 37% gross margin (up 600+ bps YoY) reflects operational excellence
- **Digital Growth Engine**: 32% Amazon/Chewy platform growth drives Q4 revenue surge
- **Asian Expansion Payoff**: $6.5M upfront deal + 3% royalty stream
- **Debt-Free Future**: $6.2M debt extinguishment gain strengthens balance sheet
- **Shareholder Returns**: Up to 55% of annual royalties to be distributed

**【CEO Business Review】**
- **Full Year 2024 Performance**: 
  - Gross profit margin improved to 37% (up 600+ basis points YoY)
  - Adjusted EBITDA loss of $1.9M (78% improvement YoY)
  - Annual net revenues of $35M
- **Key Growth Drivers**: 
  - 26% Q4 revenue growth (vs. 9% annual decline)
  - 32% growth on Amazon/Chewy platforms
  - 18% international revenue growth
- **Strategic Wins**: 
  - Signed $6.5M cash deal for Halo Asian operations with 3% royalty
  - 5.5% royalty agreement with existing Asian partner
  - Board approves up to 55% of annual royalties for shareholder distributions

**【CFO Financial Highlights】**
- **Revenue Mix**: 
  - 8% growth in key digital platforms despite 9% overall revenue decline
  - 10% increase in gross profit dollars
- **Cost Optimization**: 
  - 22% reduction in SG&A expenses
  - 40% inventory reduction while maintaining >95% service levels
- **Liquidity & Balance Sheet**: 
  - $3M cash on hand
  - $7.9M working capital (200% YoY increase)
  - $6.2M gain from debt extinguishment
- **Profitability Metrics**: 
  - GAAP net loss of $168K (vs. $23M prior year)
  - Q4 adjusted EBITDA loss of $700K (80% YoY improvement)

**【Acquisition Update】**
- **SRX Health Merger**: 
  - Expected to close in April 2025
  - Combines pet health and human wellness platforms
  - Synergies expected to drive operational efficiency and growth

Better Choice (BTTR)-27 Mar 25-2024 Q4 Earnings call transcript

Better Choice (BTTR)-12 Nov 24-2024 Q3 Earnings call transcript

Better Choice (BTTR)-10 Nov 22-2022 Q3 Earnings call transcript

Better Choice (BTTR)-14 Aug 22-2022 Q2 Earnings call transcript

Better Choice (BTTR)-15 May 22-2022 Q1 Earnings call transcript

Better Choice (BTTR)-29 Mar 22-2021 Q4 Earnings call transcript

Better Choice (BTTR)-14 Nov 21-2021 Q3 Earnings call transcript

Better Choice (BTTR)-14 Aug 21-2021 Q2 Earnings call transcript

SRXH

SRXH fundamentals

Earnings Call

You can ask Aime